Armata Pharmaceuticals Company Insiders

ARMP Stock  USD 2.00  0.05  2.44%   
Armata Pharmaceuticals employs about 66 people. The company is managed by 13 executives with a total tenure of roughly 154 years, averaging almost 11.0 years of service per executive, having 5.08 employees per reported executive. Discussion of Armata Pharmaceuticals' management performance can provide insight into the enterprise performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Armata Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
To learn how to invest in Armata Stock, please use our How to Invest in Armata Pharmaceuticals guide.

Armata Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.2509) % which means that it has lost $0.2509 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (34.3935) %, meaning that it created substantial loss on money invested by shareholders. Armata Pharmaceuticals' management efficiency ratios could be used to measure how well Armata Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/03/2025, Return On Equity is likely to grow to 2.03, while Return On Tangible Assets are likely to drop (0.99). As of 02/03/2025, Total Current Liabilities is likely to grow to about 19.9 M. Also, Liabilities And Stockholders Equity is likely to grow to about 118.8 M
As of 02/03/2025, Common Stock Shares Outstanding is likely to grow to about 43.6 M, while Net Loss is likely to drop (34.9 M).

Armata Pharmaceuticals Workforce Comparison

Armata Pharmaceuticals is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 330. Armata Pharmaceuticals retains roughly 66.0 in number of employees claiming about 20% of equities under Health Care industry.

Armata Pharmaceuticals Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Armata Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Armata Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Armata Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Armata Pharmaceuticals Notable Stakeholders

An Armata Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Armata Pharmaceuticals often face trade-offs trying to please all of them. Armata Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Armata Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Deborah MDCEO DirectorProfile
Richard RychlikVP ControllerProfile
Steven MartinAdvisorProfile
Todd MBAAdvisorProfile
Pierre KymeSenior DevelopmentProfile
Peter HubbardVice OperationsProfile
MS MDChief OfficerProfile
Duane BAVP OperationsProfile
Wenyuan ShiCoFounder ScientistProfile
David HouseSenior OfficerProfile
Brian VarnumCEO DirectorProfile
Bryan KadotaniVice OperationsProfile
Erin ButlerPrincipal AdminProfile

About Armata Pharmaceuticals Management Performance

The success or failure of an entity such as Armata Pharmaceuticals often depends on how effective the management is. Armata Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Armata management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Armata management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.94)(0.99)
Return On Capital Employed(0.57)(0.60)
Return On Assets(0.63)(0.66)
Return On Equity 1.94  2.03 

Armata Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Armata Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Armata Pharmaceuticals within its industry.

Armata Pharmaceuticals Manpower Efficiency

Return on Armata Pharmaceuticals Manpower

Revenue Per Employee68.6K
Revenue Per Executive348.4K
Net Loss Per Employee1M
Net Loss Per Executive5.3M
Working Capital Per Employee40.8K
Working Capital Per Executive206.9K

Additional Tools for Armata Stock Analysis

When running Armata Pharmaceuticals' price analysis, check to measure Armata Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Armata Pharmaceuticals is operating at the current time. Most of Armata Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Armata Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Armata Pharmaceuticals' price. Additionally, you may evaluate how the addition of Armata Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.